Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Dawnrays Pharmaceutical Holdings Ltd. ( (HK:2348) ) is now available.
Dawnrays Pharmaceutical Holdings Ltd. has announced its upcoming Annual General Meeting scheduled for May 23, 2025, in Hong Kong. Key agenda items include the consideration of financial statements for the year ending December 31, 2024, the declaration of final and special dividends, re-election of directors, and authorization for the board to manage director remunerations and re-appoint auditors. Additionally, a resolution will be considered to empower the directors to issue additional shares, which could influence the company’s capital structure and shareholder value.
More about Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical Holdings Ltd. is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It is listed on the Hong Kong Stock Exchange and focuses on the development, manufacturing, and distribution of pharmaceutical products.
YTD Price Performance: -5.74%
Average Trading Volume: 243,654
Technical Sentiment Signal: Hold
Current Market Cap: HK$1.73B
For a thorough assessment of 2348 stock, go to TipRanks’ Stock Analysis page.